Previous close | 86.12 |
Open | 85.53 |
Bid | 86.96 x 200 |
Ask | 87.37 x 100 |
Day's range | 84.05 - 87.33 |
52-week range | 49.24 - 94.57 |
Volume | |
Avg. volume | 188,529 |
Market cap | 1.568B |
Beta (5Y monthly) | 0.92 |
PE ratio (TTM) | 16.31 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 02 Jul 2010 |
1y target est | N/A |
Nektar (NKTR) reports a narrower-than-expected loss in the first quarter of 2024 and tops revenue estimates.
Insmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.
Iovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for the recently-approved melanoma drug Amtagvi in the United States.